JP2009079038A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009079038A5 JP2009079038A5 JP2008216055A JP2008216055A JP2009079038A5 JP 2009079038 A5 JP2009079038 A5 JP 2009079038A5 JP 2008216055 A JP2008216055 A JP 2008216055A JP 2008216055 A JP2008216055 A JP 2008216055A JP 2009079038 A5 JP2009079038 A5 JP 2009079038A5
- Authority
- JP
- Japan
- Prior art keywords
- topical composition
- retinoic acid
- composition according
- topical
- retinoid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 14
- 230000000699 topical effect Effects 0.000 claims 11
- 229930002330 retinoic acid Natural products 0.000 claims 4
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims 3
- 150000004492 retinoid derivatives Chemical class 0.000 claims 3
- 229960001727 tretinoin Drugs 0.000 claims 3
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 claims 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 claims 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims 2
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 claims 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 claims 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 claims 2
- -1 retinoic acid ester Chemical class 0.000 claims 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims 1
- SHGAZHPCJJPHSC-ZVCIMWCZSA-N 9-cis-retinoic acid Chemical compound OC(=O)/C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-ZVCIMWCZSA-N 0.000 claims 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 claims 1
- 235000010469 Glycine max Nutrition 0.000 claims 1
- 244000068988 Glycine max Species 0.000 claims 1
- SHGAZHPCJJPHSC-NUEINMDLSA-N Isotretinoin Chemical compound OC(=O)C=C(C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NUEINMDLSA-N 0.000 claims 1
- 239000004909 Moisturizer Substances 0.000 claims 1
- IIXHQGSINFQLRR-UHFFFAOYSA-N Piceatannol Natural products Oc1ccc(C=Cc2c(O)c(O)c3CCCCc3c2O)cc1O IIXHQGSINFQLRR-UHFFFAOYSA-N 0.000 claims 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 claims 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 claims 1
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 claims 1
- 229960002916 adapalene Drugs 0.000 claims 1
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 claims 1
- 229960001445 alitretinoin Drugs 0.000 claims 1
- 229930002945 all-trans-retinaldehyde Natural products 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000007240 daidzein Nutrition 0.000 claims 1
- 229940121647 egfr inhibitor Drugs 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- HKSZLNNOFSGOKW-UHFFFAOYSA-N ent-staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(C)O1 HKSZLNNOFSGOKW-UHFFFAOYSA-N 0.000 claims 1
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims 1
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims 1
- ADFCQWZHKCXPAJ-GFCCVEGCSA-N equol Chemical compound C1=CC(O)=CC=C1[C@@H]1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-GFCCVEGCSA-N 0.000 claims 1
- 235000019126 equol Nutrition 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 235000006539 genistein Nutrition 0.000 claims 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 claims 1
- 229940045109 genistein Drugs 0.000 claims 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N genistein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 claims 1
- ADFCQWZHKCXPAJ-UHFFFAOYSA-N indofine Natural products C1=CC(O)=CC=C1C1CC2=CC=C(O)C=C2OC1 ADFCQWZHKCXPAJ-UHFFFAOYSA-N 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229960005280 isotretinoin Drugs 0.000 claims 1
- 235000008777 kaempferol Nutrition 0.000 claims 1
- 230000001333 moisturizer Effects 0.000 claims 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 claims 1
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims 1
- CDRPUGZCRXZLFL-OWOJBTEDSA-N piceatannol Chemical compound OC1=CC(O)=CC(\C=C\C=2C=C(O)C(O)=CC=2)=C1 CDRPUGZCRXZLFL-OWOJBTEDSA-N 0.000 claims 1
- 235000005875 quercetin Nutrition 0.000 claims 1
- 229960001285 quercetin Drugs 0.000 claims 1
- 239000011604 retinal Substances 0.000 claims 1
- 230000002207 retinal effect Effects 0.000 claims 1
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 claims 1
- 229960003471 retinol Drugs 0.000 claims 1
- 235000020944 retinol Nutrition 0.000 claims 1
- 239000011607 retinol Substances 0.000 claims 1
- 229960000342 retinol acetate Drugs 0.000 claims 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims 1
- 235000019173 retinyl acetate Nutrition 0.000 claims 1
- 239000011770 retinyl acetate Substances 0.000 claims 1
- 229940108325 retinyl palmitate Drugs 0.000 claims 1
- 235000019172 retinyl palmitate Nutrition 0.000 claims 1
- 239000011769 retinyl palmitate Substances 0.000 claims 1
- HKSZLNNOFSGOKW-FYTWVXJKSA-N staurosporine Chemical compound C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1[C@H]1C[C@@H](NC)[C@@H](OC)[C@]4(C)O1 HKSZLNNOFSGOKW-FYTWVXJKSA-N 0.000 claims 1
- CGPUWJWCVCFERF-UHFFFAOYSA-N staurosporine Natural products C12=C3N4C5=CC=CC=C5C3=C3CNC(=O)C3=C2C2=CC=CC=C2N1C1CC(NC)C(OC)C4(OC)O1 CGPUWJWCVCFERF-UHFFFAOYSA-N 0.000 claims 1
- 229960000565 tazarotene Drugs 0.000 claims 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 claims 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27189401P | 2001-02-27 | 2001-02-27 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567353A Division JP2005506285A (ja) | 2001-02-27 | 2002-02-27 | 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009079038A JP2009079038A (ja) | 2009-04-16 |
| JP2009079038A5 true JP2009079038A5 (enExample) | 2009-08-27 |
Family
ID=23037535
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567353A Pending JP2005506285A (ja) | 2001-02-27 | 2002-02-27 | 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用 |
| JP2008216055A Pending JP2009079038A (ja) | 2001-02-27 | 2008-08-26 | 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002567353A Pending JP2005506285A (ja) | 2001-02-27 | 2002-02-27 | 表皮成長因子受容体を活性化するレチノイド療法、石鹸および他の刺激物による副作用を防止する目的での天然ｅｇｆｒ阻害剤の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6638543B2 (enExample) |
| EP (1) | EP1370294A2 (enExample) |
| JP (2) | JP2005506285A (enExample) |
| AU (1) | AU2002255627B2 (enExample) |
| BR (1) | BR0207663A (enExample) |
| CA (1) | CA2439408C (enExample) |
| MX (1) | MXPA03007609A (enExample) |
| WO (1) | WO2002067988A2 (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
| US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
| US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
| US20040047828A1 (en) * | 1998-08-01 | 2004-03-11 | Merck Patent Gmbh | Ectoin or ection derivatives and surfactants |
| US7144880B2 (en) | 1999-04-30 | 2006-12-05 | Regents Of The University Of Michigan | Compositions relating to novel compounds and targets thereof |
| US20060025388A1 (en) * | 1999-04-30 | 2006-02-02 | Glick Gary D | Compositions and methods relating to novel compounds and targets thereof |
| US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
| US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
| US7048910B2 (en) | 2000-09-07 | 2006-05-23 | Merck Patent Gmbh | Use of ectoine or ectoine derivatives for oral care |
| US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
| US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
| KR100358819B1 (ko) * | 2001-06-12 | 2002-10-25 | 김기홍 | 생약 패취제 |
| DE10214257A1 (de) * | 2002-03-28 | 2003-10-16 | Merck Patent Gmbh | Verwendung von kompatiblen Soluten zur Inhibierung der Freisetzung von Ceramiden |
| US20060122262A1 (en) | 2002-10-29 | 2006-06-08 | Lephart Edwin D | Use of equol for treating androgen mediated diseases |
| US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
| US9173866B2 (en) * | 2002-07-24 | 2015-11-03 | Children's Hospital Medical Center | Compositions and products containing R-equol, and methods for their making |
| WO2004022024A1 (en) * | 2002-09-07 | 2004-03-18 | Johnson & Johnson Consumer France S.A.S. | Compositions comprising soy products and organic salts of certain metals |
| CZ2005181A3 (cs) * | 2002-09-23 | 2005-08-17 | Novogen Research Pty Ltd | Léčba stárnutí pokožky vlivem světla a aktinického poškození pokožky |
| US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| US7498127B2 (en) * | 2002-12-20 | 2009-03-03 | Shigeki Higashiyama | Method of screening cell growth inhibitor and cell growth inhibitor |
| AU2004253579B2 (en) * | 2003-07-01 | 2010-12-23 | Biomol International L.P. | Sirt1 modulators for manipulating cells/organism lifespan/stress response |
| US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
| US20050171027A1 (en) * | 2003-12-29 | 2005-08-04 | President And Fellows Of Harvard College | Compositions for treating or preventing obesity and insulin resistance disorders |
| CA2564399A1 (en) * | 2004-04-28 | 2005-11-17 | Brigham Young University | Use of equol for treating skin diseases |
| US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
| CA2580329C (en) | 2004-09-13 | 2015-01-06 | Chrono Therapeutics Inc. | Biosynchronous transdermal drug delivery |
| WO2006074358A1 (en) | 2005-01-03 | 2006-07-13 | The Regents Of The University Of Michigan | Compositions and methods relating to novel compounds and targets thereof |
| US20070042026A1 (en) * | 2005-03-17 | 2007-02-22 | Wille John J | Prophylactic and therapeutic treatment of topical and transdermal drug-induced skin reactions |
| US20070014833A1 (en) * | 2005-03-30 | 2007-01-18 | Sirtris Pharmaceuticals, Inc. | Treatment of eye disorders with sirtuin modulators |
| CA2610854A1 (en) * | 2005-03-30 | 2006-10-05 | Sirtris Pharmaceuticals, Inc. | Nicotinamide riboside and analogues thereof |
| WO2006127905A2 (en) | 2005-05-24 | 2006-11-30 | Chrono Therapeutics, Inc. | Portable drug delivery device |
| WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
| FR2894821B1 (fr) * | 2005-12-15 | 2008-02-29 | Galderma Res & Dev | Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations |
| JP5023323B2 (ja) * | 2006-06-13 | 2012-09-12 | 国立大学法人 熊本大学 | アクアポリン５の発現亢進剤 |
| JP2010504974A (ja) * | 2006-09-28 | 2010-02-18 | フォリカ，インコーポレーテッド | 新しい毛嚢を生成させ毛髪を成長させる方法、キット、及び組成物 |
| US20080118449A1 (en) * | 2006-11-21 | 2008-05-22 | Alvin Ronlan | Cosmetic formulations of piceatannol and retinoids and methods of use thereof |
| JP5746807B2 (ja) | 2006-12-28 | 2015-07-08 | アルロン・ジャパン株式会社 | 皮膚用化粧品の組成物 |
| EP2120917B1 (en) * | 2007-02-28 | 2014-01-22 | University Of Kentucky Research Foundation | Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy |
| WO2009005815A1 (en) * | 2007-07-05 | 2009-01-08 | Enhanced Pharmaceuticals, Inc. | Method for determining drug-molecular combinations that modulate and enhance the therapeutic safety and efficacy of biological or pharmaceutical drugs |
| AU2010212513B2 (en) * | 2009-10-02 | 2016-08-25 | Monash University | Ectopic pregnancy treatment |
| US9126978B2 (en) | 2009-11-17 | 2015-09-08 | The Regents Of The University Of Michigan | 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| US20130017259A1 (en) | 2011-07-06 | 2013-01-17 | The Parkinson's Institute | Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients |
| US10105487B2 (en) | 2013-01-24 | 2018-10-23 | Chrono Therapeutics Inc. | Optimized bio-synchronous bioactive agent delivery system |
| CA2974324A1 (en) | 2015-01-28 | 2016-08-04 | Zita S. Netzel | Drug delivery methods and systems |
| WO2016145373A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
| EP3565617A1 (en) | 2017-01-06 | 2019-11-13 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| CA3119992A1 (en) | 2018-11-16 | 2020-05-22 | Morningside Venture Investments Limited | Thermally regulated transdermal drug delivery system |
| MX2021007678A (es) * | 2018-12-25 | 2021-08-24 | Sol Gel Tech Ltd | Tratamiento de trastornos de la piel con composiciones que comprenden un inhibidor de egfr. |
| US11633399B2 (en) | 2018-12-25 | 2023-04-25 | Sol-Gel Technologies Ltd. | Treatment of skin disorders with compositions comprising an EGFR inhibitor |
| CN114206315A (zh) * | 2019-07-24 | 2022-03-18 | 索尔-格尔科技有限公司 | 用局部他匹那洛夫-egfr抑制剂组合物治疗皮肤病 |
| KR20220097429A (ko) * | 2019-11-06 | 2022-07-07 | 솔-겔 테크놀로지스 리미티드 | 손발바닥각피증 치료 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2124059A (en) | 1982-07-09 | 1984-02-08 | Gen Electric Co Plc | Signal distribution networks |
| JPH06312919A (ja) * | 1993-05-06 | 1994-11-08 | Kao Corp | 美白剤及びこれを含有する皮膚化粧料 |
| DE4444238A1 (de) | 1994-12-13 | 1996-06-20 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus Zimtsäurederivaten und Flavonglycosiden |
| WO1998014431A1 (en) * | 1996-10-01 | 1998-04-09 | Kyowa Hakko Kogyo Co., Ltd. | Nitrogenous heterocyclic compounds |
| US5824702A (en) | 1996-06-07 | 1998-10-20 | Mount Sinai School Of Medicine Of The City University Of New York | Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
| PL188574B1 (pl) | 1996-09-27 | 2005-02-28 | Unilever Nv | Kompozycja do pielęgnacji skóry |
| US5665367A (en) * | 1996-09-27 | 1997-09-09 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Skin care compositions containing naringenin and/or quercetin and a retinoid |
| DE19713092A1 (de) * | 1997-03-27 | 1998-10-01 | Wacker Chemie Gmbh | Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung |
| AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
| FR2782919B1 (fr) * | 1998-09-04 | 2001-05-25 | Roc Sa | Composition contre le vieillissement et son utilisation |
| KR100332031B1 (ko) | 1999-06-03 | 2002-04-10 | 서경배 | 피부 주름의 개선 및 생성 억제 효과를 갖는 외용제 조성물 |
| IL151299A0 (en) * | 2000-02-16 | 2003-04-10 | Brigham & Womens Hospital | Aspirin-triggered lipid mediators |
-
2002
- 2002-02-27 MX MXPA03007609A patent/MXPA03007609A/es active IP Right Grant
- 2002-02-27 BR BR0207663-2A patent/BR0207663A/pt not_active Application Discontinuation
- 2002-02-27 WO PCT/US2002/006175 patent/WO2002067988A2/en not_active Ceased
- 2002-02-27 JP JP2002567353A patent/JP2005506285A/ja active Pending
- 2002-02-27 EP EP02725038A patent/EP1370294A2/en not_active Withdrawn
- 2002-02-27 AU AU2002255627A patent/AU2002255627B2/en not_active Expired
- 2002-02-27 CA CA2439408A patent/CA2439408C/en not_active Expired - Lifetime
- 2002-02-27 US US10/085,978 patent/US6638543B2/en not_active Expired - Lifetime
-
2003
- 2003-08-12 US US10/639,160 patent/US20040033207A1/en not_active Abandoned
-
2008
- 2008-08-26 JP JP2008216055A patent/JP2009079038A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009079038A5 (enExample) | ||
| JP2005506285A5 (enExample) | ||
| EA201171079A1 (ru) | Пенообразующая композиция для местного применения | |
| CA2439408A1 (en) | Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth factor receptor | |
| ECSP12012252A (es) | Inhibición de irritación sensorial durante el consumo de productos de tabaco no fumables | |
| BRPI0410859A (pt) | concentrado de carotenóide purificado, composição de carotenóide purificada diluìda, composição adequada para administração oral, substáncia alimentìcia ou bebida adequada para consumo de mamìfero, e, creme, loção ou ungüento tópico | |
| NO20090692L (no) | Farmasoytiske og kostholdsprodukter som omfatter vitamin K2 | |
| WO2008087348A3 (fr) | Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle | |
| NO20076019L (no) | Utvortes preparat for hud | |
| AU2014359194A1 (en) | Lipid microcapsules preferably comprising a retinoid, and composition containing same, method for the production thereof, and use thereof in dermatology | |
| EP1837056A3 (en) | Anti-aging composition containing phloretin | |
| AR032287A1 (es) | Una composicion cosmetica para el cuidado de la piel y metodos cosmeticos que utilizan dicha composicion | |
| RU2010120435A (ru) | Пероральная композиция с эффектом, направленным против старения кожи | |
| WO2012130656A3 (de) | Verfahren zur herstellung eines konditionierenden reinigungsmittels | |
| RU2009101326A (ru) | Препарат для наружного применения на кожу, содержащий тритерпеновую кислоту | |
| WO2008013669A3 (en) | Alpha hydroxy acid sustained release formulation | |
| CL2008003392A1 (es) | Composicion que comprende: a) aceite de silicona, b) lipido, y c) agua, donde la composicion es una emulsion fluida de multiples fases; metodo para enfriar la piel y controlar el sudor en la piel mediante su aplicacion. | |
| NO20084478L (no) | Konjugerte lipidderivater | |
| BRPI0413491A (pt) | sistema de gordura vegetal hidrogenada | |
| WO2009111688A3 (en) | All-trans retinoid esters as active pharmaceutical ingredients, oral and topical dosage form compositions thereof, and methods of treating skin conditions thereof | |
| TW200711663A (en) | Emulsifier system, emulsion and use thereof | |
| BR112015014187A2 (pt) | composições de xantofila e métodos de uso | |
| DE502007005594D1 (de) | Mascara mit einem Gehalt an synthetischen Wachs, Bienenwachs und synthetischen Esterwachs | |
| UA113693C2 (xx) | Титановмісна сполука, спосіб одержання титановмісної сполуки і застосування титановмісної сполуки в культивації рослин | |
| JP2008169117A5 (enExample) |